🔎 Trials Near Me

Utama › Kanser Prostat › Maryland › Baltimore

Kajian klinikal Kanser Prostat di Baltimore, MD

43 kajian untuk Kanser Prostat sedang mencari peserta di lokasi dalam dan sekitar Baltimore (dalam lingkungan kira-kira 30 batu). Buka kajian untuk melihat siapa yang layak menyertai dan cara menghubungi pasukan kajian.

Teks kajian rasmi (Bahasa Inggeris)

Mengambil peserta untuk kajian di sini? Paparkan di bahagian atas halaman ini — $99 selama 30 hari →

Testing Different Dosing Schedules of the Anti-cancer Drug, Lutetium 177Lu PSMA RLT and Its Effect on Patients With Advanced Prostate Cancer, RECIPROCAL Trial

Mengambil pesertaFasa 3
  • Maryland Proton Treatment Center, Baltimore
  • University of Maryland/Greenebaum Cancer Center, Baltimore
  • UM Baltimore Washington Medical Center/Tate Cancer Center, Glen Burnie · 9 mi jauh
  • dan 1 lagi
Umur 18 ke atas · Lelaki · Dikemas kini 2 Okt 2026 · NCT07200830

Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection

Mengambil pesertaKajian pemerhatianSukarelawan sihat dialu-alukan
  • Mercy Medical Center, Baltimore
  • Sinai Hospital of Baltimore, Baltimore
  • MedStar Franklin Square Medical Center/Weinberg Cancer Institute, Baltimore
  • dan 2 lagi
Umur 40 hingga 75 · Semua jantina · Dikemas kini 2 Okt 2026 · NCT05334069

A Study of HER3-DXd in Subjects With Locally Advanced or Metastatic Solid Tumors

Mengambil pesertaFasa 2
  • Johns Hopkins University, Baltimore
Umur 18 ke atas · Semua jantina · Dikemas kini 1 Okt 2026 · NCT06172478

Prostate Cancer Risk Identification in a Multi-Ethnic Cohort: a Prospective US-based Multi-center Validation Study of Proclarix

Mengambil pesertaKajian pemerhatian
  • Chesapeake Urology Associates, Towson · 8 mi jauh
Umur 40 hingga 75 · Lelaki · Dikemas kini 28 Sep 2026 · NCT07543757

Phase 1 Study of ACE-232 to Treat Patients With Metastatic Castration-Resistant Prostate Cancer

Mengambil pesertaFasa 1
  • University of Maryland, Greenebaum Comprehensive Cancer Center, Baltimore
Umur 18 ke atas · Lelaki · Dikemas kini 25 Sep 2026 · NCT06801236

A Study of Opevesostat (MK-5684) Versus Alternative Next-generation Hormonal Agent (NHA) in Metastatic Castration-resistant Prostate Cancer (mCRPC) Post One NHA (MK-5684-004)

Mengambil pesertaFasa 3
  • Baltimore Veterans Affairs Medical Center ( Site 0069), Baltimore
  • Greenebaum Comprehensive Cancer Center ( Site 0049), Baltimore
  • Chesapeake Urology ( Site 0009), Towson · 8 mi jauh
Umur 18 ke atas · Semua jantina · Dikemas kini 25 Sep 2026 · NCT06136650

A Study of Xaluritamig Plus Abiraterone Versus Investigator's Choice in Participants With Chemotherapy-naïve Metastatic Castration-resistant Prostate Cancer

Mengambil pesertaFasa 3
  • University of Maryland Greenebaum Cancer Center, Baltimore
  • Johns Hopkins Hospital Sidney Kimmell Comprehensive Cancer Center, Baltimore
Umur 18 ke atas · Lelaki · Dikemas kini 22 Sep 2026 · NCT07213674

A Study of Metastases Free Survival With Saruparib vs Placebo Added to a Standard RT/ADT in Men With High-risk Prostate Cancer With a BRCA Mutation

Mengambil pesertaFasa 3
  • Research Site, Towson · 8 mi jauh
Umur 18 ke atas · Lelaki · Dikemas kini 18 Sep 2026 · NCT06952803

A Clinical Study of Ifinatamab Deruxtecan (I-DXd) in People With Metastatic Prostate Cancer (MK-2400-001)

Mengambil pesertaFasa 3
  • Greenebaum Comprehensive Cancer Center ( Site 0021), Baltimore
Umur 18 ke atas · Lelaki · Dikemas kini 17 Sep 2026 · NCT06925737

PROMISE Registry: A Prostate Cancer Registry of Outcomes and Germline Mutations for Improved Survival and Treatment Effectiveness

Mengambil pesertaKajian pemerhatian
  • Johns Hopkins Sidney Kimmel Comprehensive Cancer Center, Baltimore
Umur 18 ke atas · Lelaki · Dikemas kini 15 Sep 2026 · NCT04995198

A Biomarker Study in Men With Localized Prostate Cancer Treated With Aglatimagene Besadenovec

Mengambil pesertaFasa 2
  • Chesapeake Urology Research Associates, Towson · 8 mi jauh
Umur 18 ke atas · Lelaki · Dikemas kini 15 Sep 2026 · NCT07332000

Sacral Neuromodulation for Male Overactive Bladder (MOAB)

Mengambil peserta
  • Anne Arundel Urology, Annapolis · 22 mi jauh
Umur 18 ke atas · Lelaki · Dikemas kini 14 Sep 2026 · NCT06511141

Testing Shorter Duration Radiation Therapy Versus the Usual Radiation Therapy in Patients With High Risk Prostate Cancer

Mengambil pesertaFasa 3
  • Maryland Proton Treatment Center, Baltimore
  • University of Maryland/Greenebaum Cancer Center, Baltimore
  • Veterans Administration Medical Center-Baltimore, Baltimore
  • dan 4 lagi
Umur 18 ke atas · Lelaki · Dikemas kini 10 Sep 2026 · NCT05946213

Patient Navigation Program to Improve Clinical Trial Enrollment in Cancer Patients

Mengambil peserta
  • Johns Hopkins Sidney Kimmel Comprehensive Cancer Center, Baltimore
Umur 18 ke atas · Semua jantina · Dikemas kini 3 Sep 2026 · NCT06138067

Transrectal Ultrasound Robot-Assisted Prostate Biopsy

Mengambil peserta
  • Johns Hopkins Hospital, Baltimore
Umur 45 hingga 75 · Lelaki · Dikemas kini 26 Ogo 2026 · NCT02871726

Study of Oral MRT-2359 With Apalutamide in Prostate Cancer

Mengambil pesertaFasa 2
  • University of Maryland Greenebaum Cancer Center, Baltimore
Umur 18 ke atas · Lelaki · Dikemas kini 24 Ogo 2026 · NCT07745361

A Phase 1b/2a Study of Pocenbrodib as Monotherapy and in Combination With Darolutamide in Participants With mCRPC

Mengambil pesertaFasa 1/2
  • Johns Hopkins Hospital, Baltimore
Umur 18 ke atas · Lelaki · Dikemas kini 20 Ogo 2026 · NCT06785636

Treating Prostate Cancer That Has Come Back After Surgery With Apalutamide and Targeted Radiation Based on PET Imaging

Mengambil pesertaFasa 3
  • Johns Hopkins University/Sidney Kimmel Cancer Center, Baltimore
Umur 18 ke atas · Lelaki · Dikemas kini 19 Ogo 2026 · NCT04423211

FOG-001 in Locally Advanced or Metastatic Solid Tumors

Mengambil pesertaFasa 1/2
  • Johns Hopkins University, The Sidney Kimmel Comprehensive Cancer Center, Baltimore
Umur 18 ke atas · Semua jantina · Dikemas kini 17 Ogo 2026 · NCT05919264

Study of JANX007 in Subjects With Metastatic Castration-Resistant Prostate Cancer (ENGAGER-PSMA-01)

Mengambil pesertaFasa 1
  • University of Maryland Greenebaum Comprehensive Cancer Center, Baltimore
Umur 18 hingga 100 · Lelaki · Dikemas kini 13 Ogo 2026 · NCT05519449

Impact of DNA Repair Pathway Alterations on Sensitivity to Radium-223 in Bone Metastatic Castration-resistant Prostate Cancer

Mengambil pesertaKajian pemerhatian
  • Johns Hopkins University, Baltimore
Umur 18 ke atas · Lelaki · Dikemas kini 12 Ogo 2026 · NCT04489719

Docetaxel to Androgen Receptor Pathway Inhibitors in Patients With Metastatic Castration Sensitive Prostate Cancer and Suboptimal PSA Response

Mengambil pesertaFasa 3
  • Johns Hopkins University/Sidney Kimmel Cancer Center, Baltimore
Umur 18 ke atas · Lelaki · Dikemas kini 14 Jul 2026 · NCT06592924

Testing the Safety and Effectiveness of Radiation-based Treatment (Lutetium Lu 177 Dotatate) for Metastatic Prostate Cancer That Has Neuroendocrine Cells

Mengambil pesertaFasa 2
  • Johns Hopkins University/Sidney Kimmel Cancer Center, Baltimore
Umur 18 ke atas · Lelaki · Dikemas kini 14 Jul 2026 · NCT05691465

Study of ORIC-944 in Patients With Metastatic Prostate Cancer

Mengambil pesertaFasa 1
  • Marlene & Stewart Greenebaum Comprehensive Cancer Center, University of Maryland, Baltimore
Umur 18 ke atas · Lelaki · Dikemas kini 9 Jul 2026 · NCT05413421

7-Days Water-Only Fasting or Ketone Supplementation Trial in Prostate Cancer

Mengambil peserta
  • Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore
Umur 18 ke atas · Lelaki · Dikemas kini 30 Jun 2026 · NCT06826924

The COSMYC Trial (COmbined Suppression of MYC)

Mengambil pesertaFasa 2
  • Johns Hopkins Sidney Kimmel Comprehensive Cancer Center, Baltimore
Umur 18 ke atas · Lelaki · Dikemas kini 18 Jun 2026 · NCT06922318

Safety and Tolerability of ²¹²Pb-DOTAM-GRPR1 in Adult Subjects With Recurrent or Metastatic GRPR-expressing Tumors

Mengambil pesertaFasa 1
  • Advanced Molecular Imaging and Therapy, Glen Burnie · 9 mi jauh
  • United Theranostics - Chesapeake, Glen Burnie · 9 mi jauh
Umur 18 ke atas · Semua jantina · Dikemas kini 11 Jun 2026 · NCT05283330

TERPS Trial for de Novo Oligometastic Prostate Cancer

Mengambil pesertaFasa 2
  • Maryland Proton Treatment Center, Baltimore
  • UMMC, Baltimore
  • Baltimore Washington Medical Center, Glen Burnie · 9 mi jauh
  • dan 1 lagi
Umur 18 ke atas · Lelaki · Dikemas kini 3 Jun 2026 · NCT05223803

International Registry for Men With Advanced Prostate Cancer (IRONMAN)

Mengambil pesertaKajian pemerhatian
  • Johns Hopkins Sidney Kimmel Comprehensive Cancer Center, Baltimore
Umur 21 ke atas · Lelaki · Dikemas kini 22 Mei 2026 · NCT03151629

Clinical Trial of Approaches to Prostate Cancer Surgery

Mengambil peserta
  • Johns Hopkins University, Baltimore
Umur 40 hingga 80 · Lelaki · Dikemas kini 22 Apr 2026 · NCT05155501

Veterans Affairs Seamless Phase II/III Randomized Trial of STAndard Systemic theRapy With or Without PET-directed Local Therapy for Oligometastatic pRosTate Cancer

Mengambil pesertaFasa 2/3
  • Baltimore VA Medical Center VA Maryland Health Care System, Baltimore, MD, Baltimore
Umur 18 ke atas · Lelaki · Dikemas kini 8 Apr 2026 · NCT04787744

SPECT Imaging for Pharmacokinetics and dosimEtry Towards TREATment Optimization

Mengambil pesertaKajian pemerhatian
  • Johns Hopkins University, Baltimore
Umur 18 hingga 100 · Semua jantina · Dikemas kini 30 Mac 2026 · NCT06389097

Supraphysiologic Testosterone Priming Induces Darolutamide Extended Response

Mengambil pesertaFasa 2
  • Johns Hopkins Sidney Kimmel Comprehensive Cancer Center, Baltimore
Umur 18 ke atas · Lelaki · Dikemas kini 11 Mac 2026 · NCT07142551

Trial Targeting Gut Bacterial Androgen Production to Reverse Therapeutic Resistance to Abiraterone in Patients With Metastatic Prostate Cancer

Mengambil pesertaFasa 2
  • Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore
Umur 18 ke atas · Lelaki · Dikemas kini 19 Feb 2026 · NCT06616597

Image-guided Focal Brachytherapy Utilizing Combined 18F-DCFPyl PET/CT

Mengambil pesertaFasa awal 1
  • SKCCC at Johns Hopkins, Baltimore
Umur 18 hingga 100 · Lelaki · Dikemas kini 13 Feb 2026 · NCT03861676

A Study of CLSP-1025 in Adult Patients With Solid Tumors That Harbor the p53 R175H Mutation

Mengambil pesertaFasa 1
  • Johns Hopkins - Sidney Kimmel Comprehensive Cancer Center, Baltimore
Umur 18 ke atas · Semua jantina · Dikemas kini 13 Feb 2026 · NCT06778863

A Safety and Dose-finding Study of PRL-02 Depot in Men With Advanced Prostate Cancer

Mengambil pesertaFasa 1
  • Chesapeake Urology, Towson · 8 mi jauh
Umur 18 ke atas · Lelaki · Dikemas kini 4 Feb 2026 · NCT04729114

Physician- and Patient-based Barriers to NGS Testing

Mengambil peserta
  • Johns Hopkins Sidney Kimmel Comprehensive Cancer Center, Baltimore
Umur 18 ke atas · Lelaki · Dikemas kini 3 Feb 2026 · NCT07209176

Difluoromethylornithine and High Dose Testosterone With Enzalutamide in Metastatic Castration-Resistant Prostate Cancer

Mengambil pesertaFasa 2
  • Johns Hopkins University: Sidney Kimmel Comprehensive Cancer Center, Baltimore
Umur 18 ke atas · Lelaki · Dikemas kini 14 Jan 2026 · NCT06059118

Robot-Assisted Prostate Biopsy With a Novel Ultrasound Probe

Mengambil pesertaFasa 1
  • Johns Hopkins Hospital, Baltimore
Umur 40 hingga 75 · Lelaki · Dikemas kini 8 Dis 2025 · NCT07271017

SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry

Mengambil pesertaKajian pemerhatian
  • Massive Bio SYNERGY-AI site, Baltimore
  • Massive Bio SYNERGY-AI site, Towson · 8 mi jauh
Semua umur · Semua jantina · Dikemas kini 28 Okt 2025 · NCT03452774

Exercise in Prostate Cancer

Mengambil peserta
  • Johns Hopkins University, Baltimore
Umur 18 hingga 80 · Semua jantina · Dikemas kini 20 Okt 2025 · NCT06165302

A Trial of AMXI-5001 for Treatment in Patients With Advanced Malignancies

Mengambil pesertaFasa 1/2
  • Johns Hopkins, Baltimore
Umur 18 ke atas · Semua jantina · Dikemas kini 1 Mei 2025 · NCT04503265

Kajian Kanser Prostat di bandar lain

Kajian lain di Baltimore

Daripada ClinicalTrials.gov, data diperoleh pada 5 Okt 2026. Setiap kajian menetapkan kriteria kelayakannya sendiri; pasukan kajian menentukan siapa yang layak menyertai.